Track the 에스알바이오텍 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 에스알바이오텍 has logged 13 reports. The latest transaction was filed on 13 February 2026 (Purchase). Among the most active insiders: 비에이파트너스. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
13 of 13 declarations
Listed on the XKRX market, SR Biotech specializes in the health and pharmaceutical sector. The company focuses on developing innovative biopharmaceutical solutions.